help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on May 8, 2008
Am. J. Respir. Crit. Care Med. 2008, doi:10.1164/rccm.200803-381OC
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Campos, M.
Right arrow Articles by Ashkin, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campos, M.
Right arrow Articles by Ashkin, D.

Submitted on March 6, 2008
Accepted on May 8, 2008

Feasibility of Shortening Respiratory Isolation with a Single Sputum Nucleic Acid Amplification Test

Michael Campos1*, Andrew Quartin1, Eliana Mendes1, Alexandre Abreu1, Samuel Gurevich1, Luis Echarte1, Tanira Ferreira2, Timothy Cleary1, Elena Hollender3, and David Ashkin3

1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USA, 2 A.G. Holley State Hospital, Lantana, FL, USA, 3 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USA; A.G. Holley State Hospital, Lantana, FL, USA

* To whom correspondence should be addressed. E-mail: mcampos1{at}med.miami.edu.

Rationale: Serial smear analysis to guide respiratory isolation (RI) of tuberculosis (TB) suspects, the majority of whom will be found not to not have TB, leads to expensive and unnecessary isolation, and may potentially result in decreased vigilance of subjects with respiratory compromise. Objective: To compare the performance of a single first-sputum, TB Mycobacterium tuberculosis-specific nucleic acid amplification (NAA) test to three sputum smears for assessing the need for RI. Methods: Prospective evaluation of 493 TB suspects (74% HIV-positive) admitted to RI toin a major county hospital in the United States, who had at least 3 sputum smears and material available from the first sample for additional NAA testing. Measurements: Accuracy of the first sputum NAA result and serial smears for identifying potentially infectious TB patients and the need for RI. Main Results: 46 patients (9.3%) had TB confirmed by culture. First-sputum NAA test detected all TB patients who had a positive smear (n = 35), even when the first of the three specimens was smear-negative. In addition, when compared with serial smears, the first-sputum NAA had a higher sensitivity (0.87, 95%CI 0.74-0.95) and specificity (1.0) in the detection of subjects with positive M. tuberculosis cultures (smear sensitivity 0.76, 95% CI 0.61-0.87 and specificity 0.96, 95%CI 0.94-0.98). Conclusions: A single first-sputum NAA testing can rapidly and accurately identify the subset of TB suspects who require RI according to serial sputum smears. Its potential use to shorten RI time does not preclude the need to obtain subsequent specimens for culture.


Key words: Tuberculosis, diagnosis, nucleic acid amplification, diagnostic test, sensitivity







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society